Acquisition by Krogulski Kenneth of 266 shares of Cumberland Pharmaceuticals at 2.33 subject to Rule 16b-3
| BQST Stock | USD 1.10 0.05 4.76% |
Slightly above 55% of BioQuest Corp's private investors are presently thinking to get in. The analysis of overall sentiment of trading BioQuest Corp pink sheet suggests that some investors are interested at this time. BioQuest Corp's investing sentiment can be driven by a variety of factors including economic data, BioQuest Corp's earnings reports, geopolitical events, and overall market trends.
BioQuest |
Filed transaction by Cumberland Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
BioQuest Corp Fundamental Analysis
We analyze BioQuest Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioQuest Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioQuest Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
BioQuest Corp is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
BioQuest Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioQuest Corp pink sheet to make a market-neutral strategy. Peer analysis of BioQuest Corp could also be used in its relative valuation, which is a method of valuing BioQuest Corp by comparing valuation metrics with similar companies.
Peers
BioQuest Corp Related Equities
| ETST | Earth Science | 9.52 | ||||
| CPIX | Cumberland Pharmaceuticals | 3.60 | ||||
| HYPMY | Hypera SA | 0.32 |
Additional Tools for BioQuest Pink Sheet Analysis
When running BioQuest Corp's price analysis, check to measure BioQuest Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioQuest Corp is operating at the current time. Most of BioQuest Corp's value examination focuses on studying past and present price action to predict the probability of BioQuest Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioQuest Corp's price. Additionally, you may evaluate how the addition of BioQuest Corp to your portfolios can decrease your overall portfolio volatility.